Document is current
Any future updates will be listed below
-
Authors
Martorell-Marugán, Jordi http://orcid.org/0000-0002-5186-0735
López-Domínguez, Raúl
García-Moreno, Adrián
Toro-Domínguez, Daniel
Villatoro-García, Juan Antonio
Barturen, Guillermo
Martín-Gómez, Adoración
Troule, Kevin
Gómez-López, Gonzalo
Al-Shahrour, Fátima
González-Rumayor, Víctor
Peña-Chilet, María
Dopazo, Joaquín
Sáez-Rodríguez, Julio
Alarcón-Riquelme, Marta E.
Carmona-Sáez, Pedro http://orcid.org/0000-0002-6173-7255
-
Funding
Funding for this research was provided by:
Consejería de Economía y Conocimiento, Junta de Andalucía (CV20-36723)
Consejería de Salud, Junta de Andalucía (PI‐0173‐2017)
Innovative Medicines Initiative (GA-115565)
- License Information
-
More Information
Article History
Received: 8 November 2020
Accepted: 14 June 2021
First Online: 24 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: JMM and VGR are employees of Atrys Health S.A. and the company has no competing interests with the published results. JSR has received funding from GSK and Sanofi and expects consultant fees from Travere Therapeutics. The rest of the authors declare that they have no competing interests.
